Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Hu: Unmasking Conserved Epitopes |
| Strategy: | Combo: DNA, protein & vector vaccines |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2014-04-08 |
| Study Made Public: | 2017-07-27 |
Title
NHP Immuongenicity Study of Heterologous N7 Prime-Boost Immunization- MX1
Description
CAVD 451 (MX1) is a non-human primate study to evaluate the antibody responses following vaccinia vector and heterologous N7 Env prime/boost regimens.
Sign in to see full information about this study and to download study data.
Products
Alum DNA-SIV-Gag-Pol v-NY-SIV gag/pol Env gp120 (89.6 N7) v-NY-Env gp160 (89.6 N7) JRFL gp120 Placebo vaccinia PV0.4 N7 gp120 v-NY Env gp160 (N7 mix) Env gp120 (N7 mix) 1084i (C) N7 gp120 v-WR Env gp160 (89.6 N7)Integrated data
BAMA, ICS, NAb
Non-integrated data
No non-integrated data is available for this study.